Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesRSNA 2025MRI study finds sex differences in knee injuriesOlder women appear to be more prone to injuries that lead to joint degeneration over time.Womens ImagingRadiologist performance, patient factors tied to interval cancer riskPractice ManagementMICI Q4: Radiology admins' confidence varies regarding medical imagingRSNA 2025Image-only AI model improves breast cancer risk assessmentSponsor ContentClinically Meaningful AI Detection of Interval Cancers